Algorae Pharmaceuticals Limited

Research Algorae Pharmaceuticals Limited (LHI0) on Bullrun: market cap EUR 9.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLHI0
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 9.12M
• Financial periodFY2024
• Net income-EUR 2.10M
• Free cash flow-EUR 1.52M

Valuation Snapshot

latest market cap is EUR 9.12M.

About Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer's disease;

Frequently asked questions

What is Algorae Pharmaceuticals Limited's market cap?

Algorae Pharmaceuticals Limited's market capitalization is EUR 9.12M.

What does Algorae Pharmaceuticals Limited do?

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.